UNIGENE LABORATORIES INC·4

Jan 17, 5:13 PM ET

Thomas Jenene D. 4

4 · UNIGENE LABORATORIES INC · Filed Jan 17, 2012

Insider Transaction Report

Form 4
Period: 2012-01-13
Thomas Jenene D.
VP of Investor Relations
Transactions
  • Award

    Stock Option

    2012-01-13+10,125383,325 total
    Exercise: $0.65From: 2012-12-31Exp: 2022-01-12common stock (10,125 underlying)
  • Award

    Stock Option

    2012-01-13+43,200373,200 total
    Exercise: $0.65From: 2012-12-31Exp: 2022-01-12common stock (43,200 underlying)

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    PRIMARY DOCUMENT